Table 2 Mean IOP in different groups of glaucoma at all examination time points
From: Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma
|  | baseline | 2 days | 1 month | 3 months | 6 months | 12 months | p= | mean reduction [%] |
|---|---|---|---|---|---|---|---|---|
complete group | 23.9 ± 7.4 | 9.2 ± 5.2 | 15.5 ± 7.9 | 15.9 ± 6.1 | 15.7 ± 6.7 | 15.4 ± 5.1 | < 0.01 | −31.3 ± 23.9 |
POAG | 22.8 ± 6.5 | 8.9 ± 5.1 | 15.3 ± 7.6 | 15.9 ± 6.0 | 15.3 ± 6.2 | 15.1 ± 4.6 | < 0.01 | −29.8 ± 23.8 |
NTG | 16.6 ± 3.4 | 5.6 ± 2.7 | 10.0 ± 3.0 | 13.4 ± 2.9 | 10.8 ± 4.6 | 11.6 ± 2.2 | < 0.05 | −28.6 ± 18.4 |
PEX | 28.0 ± 7.9 | 11.9 ± 6.4 | 16.5 ± 8.0 | 15.7 ± 6.2 | 17.1 ± 7.2 | 17.1 ± 6.6 | < 0.01 | −37.8 ± 17.9 |
secondary glaucoma | 28.9 ± 13.9 | 8.7 ± 4.6 | 16.7 ± 10.6 | 17.7 ± 10.3 | 17.0 ± 10.4 | 15.5 ± 6.9 | < 0.05 | −35.7 ± 36.3 |